|
Message Board >
[Upcoming Webinar] Breaking the Delivery Barrier:
[Upcoming Webinar] Breaking the Delivery Barrier:
Page:
1
Guest
Guest
Apr 13, 2026
11:23 PM
|
In the world of genomic medicine, the CRISPR/Cas9 system is the ultimate "molecular scissor." However, even the sharpest tool is ineffective if it cannot reach its target. For researchers tackling complex diseases like lung tumors, the challenge has always been delivery.
To address this bottleneck, Creative Biolabs is hosting an exclusive webinar: "Optimization of Lipid Nanoparticles for CRISPR/Cas9 Delivery: Strategies to Enhance Gene Editing in Lung Tumor Models."
Why LNP Optimization is the Key
Lipid Nanoparticles (LNPs) have revolutionized the delivery of nucleic acids, as seen in the success of mRNA vaccines. Yet, delivering CRISPR components to lung tumors requires a higher level of sophistication. Factors such as endosomal escape, tissue-specific targeting, and serum stability are all dictated by the precise chemical architecture of the LNP.
Small adjustments in the molar ratios of ionizable lipids, helper lipids, and PEG-lipids can mean the difference between clinical success and therapeutic failure.
What You Will Learn
This webinar dives deep into the engineering strategies used to bypass biological barriers. Key highlights include:
Custom Formulation: How to tailor LNP compositions specifically for large CRISPR/Cas9 mRNA and sgRNA payloads.
Targeting Lung Microenvironments: Innovative chemical modifications that prioritize LNP accumulation in lung tissues.
In Vivo Performance: Real-world data demonstrating enhanced gene editing efficiency in lung tumor models.
Scalability & Stability: Transitioning from benchtop formulations to clinical-grade production.
Join the Discussion
Whether you are a molecular biologist, a formulation scientist, or a drug developer, this session will provide actionable insights into the future of non-viral delivery systems. Stay ahead of the curve and learn how to optimize your delivery platform for maximum impact.
Reserve your spot today by clicking the link below:
Register Now: Optimization of Lipid Nanoparticles for CRISPR/Cas9 Delivery
Webinar at a Glance
Topic: Optimization of Lipid Nanoparticles for CRISPR/Cas9 Delivery
Date: May 19, 2026
Speaker: Leading Scientists from Creative Biolabs
Cost: Free Registration
Meet Our Expert Speaker
We are honored to host Dr. Simone Pinto Carneiro, a distinguished pharmacist and Group Leader at LMU Munich. With over a decade of expertise in RNA-lipid nanoparticle engineering, Dr. Carneiro has been at the forefront of developing non-viral delivery strategies for pulmonary diseases. In this session, she will share her team's pioneering research on optimizing LNPs to specifically target KRAS mutations in lung cancer models, offering a rare look at the data driving the next generation of gene therapies.
|
Post a Message
Real Estate Provider #515.000066/Fahim Muhammad Instructor #512.003026/Fahim Muhammad Managing Broker #471.020985 Freedom Financial Institute, IDOI Provider #500026517/NMLS Provider #1405073/Fahim Muhammad NMLS #1851084 All loans originated through Mortgage Loan Direct, NMLS #1192858 15255 South 94th Avenue, Suite 500 Orland Park, IL 60462. Freedom Apex Enterprise & Financial Services Mailing Address: 837 East 162nd Street, Suite 7-8 South Holland, IL 60473 708-704-7309/708-566-1222, 844-49-FREEDOM
FINRA Broker Check
Disclaimer and Release Nothing contained on this website constitutes tax, legal, insurance or investment advice, or the recommendation of or an offer to sell, or the solicitation of an offer to buy or invest in any investment product, vehicle, service or instrument.The information shared is hypothetical and for informational and educational purposes only. Such an offer or solicitation may only be made and discussed by a registered representative of a broker dealer or investment advisor representative of an investment advising firm. You should note that the information and materials are provided "as is" without any express or implied warranties. Past performance is not a guarantee of future results. All investments involve a degree of risk, including a degree of loss. No part of FTAMG’s materials may be reproduced in any form, or referred to in any other publication, without express written permission from FTAMG and or its affiliates. Links to appearances and articles by Fahim Muhammad, The Freedom Coach, whether in the press, on television or otherwise, are provided for informational and educational purposes only and in no way should be considered a recommendation of any particular investment product, vehicle, service or instrument or the rendering of investment advice, which must always be evaluated by a prospective investor in consultation with his or her own financial adviser and in light of his or her own circumstances, including the investor's investment horizon, appetite for risk, and ability to withstand a potential loss of some or all of an investment's value. By using this website, you acknowledge that you have read and understand the foregoing disclaimers and release FTAMG and its affiliates, members, officers, employees and agents from any and all liability whatsoever relating to your use of this site, any such links, or any information contained herein or in any such appearances or articles (whether accessed through such links or downloaded directly from this website). FTAMG highly encourages its viewers and potential clients to obtain the independent advice and services of legal, financial, and tax professionals.
Securities offered through The Leaders Group, Inc. member FINRA/SIPC 475 Springfield Avenue, Suite 1 Summit, NJ 07901 (303) 797-9080
info@freedomfinancialinstitute.orgCopyright© 2025 - Fahim Muhammad Freedom Financial Institute, Inc.
|
|
|
